Trends in the global burden of childhood meningitis between 1990 and 2021 and projections to 2035: based on the global burden of diseases database 2021

1990年至2021年全球儿童脑膜炎负担趋势及至2035年预测:基于2021年全球疾病负担数据库

阅读:2

Abstract

OBJECTIVE: This study aimed to assess trends in the incidence, mortality and disability-adjusted life years (DALYs) of meningitis in children aged 0-14 years between 1990 and 2021 worldwide. METHODS: This study analysed the incidence, mortality and DALYs of meningitis in children aged 0-14 years in 204 countries between 1990 and 2021 and used a mixed effects regression model to calculate the average annual percentage change. The Markov chain Monte Carlo method was used to quantify uncertainty (95% uncertainty interval). RESULTS: In 2021, the global incidence of meningitis in children aged 0-14 years was 66.24 per 100,000, and the mortality rate was 5.59 per 100,000. Between 1990 and 2021, the global incidence decreased by 282.70%, and the mortality rate decreased by 310.8%. The incidence and mortality rates were highest in neonates and children aged 1-5 months, at 1,185.02 per 100,000 and 541.35 per 100,000, respectively. According to the socio-demographic index (SDI) stratifications, low SDI areas have the heaviest burden. Pathogen analysis showed that the main pathogens causing meningitis in children aged 0-14 years worldwide in 2021 included Streptococcus pneumoniae, Neisseria meningitidis and Klebsiella pneumoniae, of which S. pneumoniae caused 1.69632 million DALYs, N. meningitidis caused 1.41484 million DALYs and K. pneumoniae caused 1.19393 million DALYs. By 2035, N. meningitidis will become the main pathogen. CONCLUSION: The burden of meningitis in children has decreased significantly worldwide, but those in low-income areas and newborns still face severe challenges. Streptococcus pneumoniae, N. meningitidis and K. pneumoniae are the main pathogens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。